Global Cannabis Use Disorder Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Cannabis Use Disorder Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cannabis Use Disorder Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cannabis Use Disorder Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cannabis Use Disorder Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cannabis Use Disorder Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cannabis Use Disorder Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cannabis Use Disorder Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cannabis Use Disorder Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Alkermes, BioCorRx, Cipla Limited and Dr. Reddy’s Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cannabis Use Disorder Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Cannabis Use Disorder Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cannabis Use Disorder Treatment, with revenue, gross margin and global market share of Cannabis Use Disorder Treatment from 2018 to 2023.
Chapter 3, the Cannabis Use Disorder Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cannabis Use Disorder Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cannabis Use Disorder Treatment.
Chapter 13, to describe Cannabis Use Disorder Treatment research findings and conclusion.
This report is a detailed and comprehensive analysis for global Cannabis Use Disorder Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cannabis Use Disorder Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cannabis Use Disorder Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cannabis Use Disorder Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cannabis Use Disorder Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cannabis Use Disorder Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cannabis Use Disorder Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Alkermes, BioCorRx, Cipla Limited and Dr. Reddy’s Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cannabis Use Disorder Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Tobacco/Nicotine and Vaping
- Alcohol
- Marijuana
- Synthetic Cannabinoids
- Others
- Hospitals and Clinics
- Rehabilitation Centers
- Others
- AbbVie
- Alkermes
- BioCorRx
- Cipla Limited
- Dr. Reddy’s Laboratories
- Glenmark Pharmaceuticals Limited
- Intas Pharmaceuticals Limited
- Indivior
- Mallinckrodt
- Noramco
- Orexo AB
- Purdue Pharma
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cannabis Use Disorder Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cannabis Use Disorder Treatment, with revenue, gross margin and global market share of Cannabis Use Disorder Treatment from 2018 to 2023.
Chapter 3, the Cannabis Use Disorder Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cannabis Use Disorder Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cannabis Use Disorder Treatment.
Chapter 13, to describe Cannabis Use Disorder Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cannabis Use Disorder Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cannabis Use Disorder Treatment by Type
1.3.1 Overview: Global Cannabis Use Disorder Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cannabis Use Disorder Treatment Consumption Value Market Share by Type in 2022
1.3.3 Tobacco/Nicotine and Vaping
1.3.4 Alcohol
1.3.5 Marijuana
1.3.6 Synthetic Cannabinoids
1.3.7 Others
1.4 Global Cannabis Use Disorder Treatment Market by Application
1.4.1 Overview: Global Cannabis Use Disorder Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Rehabilitation Centers
1.4.4 Others
1.5 Global Cannabis Use Disorder Treatment Market Size & Forecast
1.6 Global Cannabis Use Disorder Treatment Market Size and Forecast by Region
1.6.1 Global Cannabis Use Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cannabis Use Disorder Treatment Market Size by Region, (2018-2029)
1.6.3 North America Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Cannabis Use Disorder Treatment Product and Solutions
2.1.4 AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Alkermes
2.2.1 Alkermes Details
2.2.2 Alkermes Major Business
2.2.3 Alkermes Cannabis Use Disorder Treatment Product and Solutions
2.2.4 Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alkermes Recent Developments and Future Plans
2.3 BioCorRx
2.3.1 BioCorRx Details
2.3.2 BioCorRx Major Business
2.3.3 BioCorRx Cannabis Use Disorder Treatment Product and Solutions
2.3.4 BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioCorRx Recent Developments and Future Plans
2.4 Cipla Limited
2.4.1 Cipla Limited Details
2.4.2 Cipla Limited Major Business
2.4.3 Cipla Limited Cannabis Use Disorder Treatment Product and Solutions
2.4.4 Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cipla Limited Recent Developments and Future Plans
2.5 Dr. Reddy’s Laboratories
2.5.1 Dr. Reddy’s Laboratories Details
2.5.2 Dr. Reddy’s Laboratories Major Business
2.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Solutions
2.5.4 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Dr. Reddy’s Laboratories Recent Developments and Future Plans
2.6 Glenmark Pharmaceuticals Limited
2.6.1 Glenmark Pharmaceuticals Limited Details
2.6.2 Glenmark Pharmaceuticals Limited Major Business
2.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
2.6.4 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Glenmark Pharmaceuticals Limited Recent Developments and Future Plans
2.7 Intas Pharmaceuticals Limited
2.7.1 Intas Pharmaceuticals Limited Details
2.7.2 Intas Pharmaceuticals Limited Major Business
2.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
2.7.4 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Intas Pharmaceuticals Limited Recent Developments and Future Plans
2.8 Indivior
2.8.1 Indivior Details
2.8.2 Indivior Major Business
2.8.3 Indivior Cannabis Use Disorder Treatment Product and Solutions
2.8.4 Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Indivior Recent Developments and Future Plans
2.9 Mallinckrodt
2.9.1 Mallinckrodt Details
2.9.2 Mallinckrodt Major Business
2.9.3 Mallinckrodt Cannabis Use Disorder Treatment Product and Solutions
2.9.4 Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mallinckrodt Recent Developments and Future Plans
2.10 Noramco
2.10.1 Noramco Details
2.10.2 Noramco Major Business
2.10.3 Noramco Cannabis Use Disorder Treatment Product and Solutions
2.10.4 Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Noramco Recent Developments and Future Plans
2.11 Orexo AB
2.11.1 Orexo AB Details
2.11.2 Orexo AB Major Business
2.11.3 Orexo AB Cannabis Use Disorder Treatment Product and Solutions
2.11.4 Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Orexo AB Recent Developments and Future Plans
2.12 Purdue Pharma
2.12.1 Purdue Pharma Details
2.12.2 Purdue Pharma Major Business
2.12.3 Purdue Pharma Cannabis Use Disorder Treatment Product and Solutions
2.12.4 Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Purdue Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cannabis Use Disorder Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cannabis Use Disorder Treatment by Company Revenue
3.2.2 Top 3 Cannabis Use Disorder Treatment Players Market Share in 2022
3.2.3 Top 6 Cannabis Use Disorder Treatment Players Market Share in 2022
3.3 Cannabis Use Disorder Treatment Market: Overall Company Footprint Analysis
3.3.1 Cannabis Use Disorder Treatment Market: Region Footprint
3.3.2 Cannabis Use Disorder Treatment Market: Company Product Type Footprint
3.3.3 Cannabis Use Disorder Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cannabis Use Disorder Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cannabis Use Disorder Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Cannabis Use Disorder Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
6.2 North America Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
6.3 North America Cannabis Use Disorder Treatment Market Size by Country
6.3.1 North America Cannabis Use Disorder Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
7.2 Europe Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
7.3 Europe Cannabis Use Disorder Treatment Market Size by Country
7.3.1 Europe Cannabis Use Disorder Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7.3.3 France Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region
8.3.1 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Region (2018-2029)
8.3.2 China Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.5 India Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
9.2 South America Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
9.3 South America Cannabis Use Disorder Treatment Market Size by Country
9.3.1 South America Cannabis Use Disorder Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country
10.3.1 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cannabis Use Disorder Treatment Market Drivers
11.2 Cannabis Use Disorder Treatment Market Restraints
11.3 Cannabis Use Disorder Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Cannabis Use Disorder Treatment Industry Chain
12.2 Cannabis Use Disorder Treatment Upstream Analysis
12.3 Cannabis Use Disorder Treatment Midstream Analysis
12.4 Cannabis Use Disorder Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Cannabis Use Disorder Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cannabis Use Disorder Treatment by Type
1.3.1 Overview: Global Cannabis Use Disorder Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cannabis Use Disorder Treatment Consumption Value Market Share by Type in 2022
1.3.3 Tobacco/Nicotine and Vaping
1.3.4 Alcohol
1.3.5 Marijuana
1.3.6 Synthetic Cannabinoids
1.3.7 Others
1.4 Global Cannabis Use Disorder Treatment Market by Application
1.4.1 Overview: Global Cannabis Use Disorder Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Rehabilitation Centers
1.4.4 Others
1.5 Global Cannabis Use Disorder Treatment Market Size & Forecast
1.6 Global Cannabis Use Disorder Treatment Market Size and Forecast by Region
1.6.1 Global Cannabis Use Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cannabis Use Disorder Treatment Market Size by Region, (2018-2029)
1.6.3 North America Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cannabis Use Disorder Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Cannabis Use Disorder Treatment Product and Solutions
2.1.4 AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Alkermes
2.2.1 Alkermes Details
2.2.2 Alkermes Major Business
2.2.3 Alkermes Cannabis Use Disorder Treatment Product and Solutions
2.2.4 Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alkermes Recent Developments and Future Plans
2.3 BioCorRx
2.3.1 BioCorRx Details
2.3.2 BioCorRx Major Business
2.3.3 BioCorRx Cannabis Use Disorder Treatment Product and Solutions
2.3.4 BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioCorRx Recent Developments and Future Plans
2.4 Cipla Limited
2.4.1 Cipla Limited Details
2.4.2 Cipla Limited Major Business
2.4.3 Cipla Limited Cannabis Use Disorder Treatment Product and Solutions
2.4.4 Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cipla Limited Recent Developments and Future Plans
2.5 Dr. Reddy’s Laboratories
2.5.1 Dr. Reddy’s Laboratories Details
2.5.2 Dr. Reddy’s Laboratories Major Business
2.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Solutions
2.5.4 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Dr. Reddy’s Laboratories Recent Developments and Future Plans
2.6 Glenmark Pharmaceuticals Limited
2.6.1 Glenmark Pharmaceuticals Limited Details
2.6.2 Glenmark Pharmaceuticals Limited Major Business
2.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
2.6.4 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Glenmark Pharmaceuticals Limited Recent Developments and Future Plans
2.7 Intas Pharmaceuticals Limited
2.7.1 Intas Pharmaceuticals Limited Details
2.7.2 Intas Pharmaceuticals Limited Major Business
2.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
2.7.4 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Intas Pharmaceuticals Limited Recent Developments and Future Plans
2.8 Indivior
2.8.1 Indivior Details
2.8.2 Indivior Major Business
2.8.3 Indivior Cannabis Use Disorder Treatment Product and Solutions
2.8.4 Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Indivior Recent Developments and Future Plans
2.9 Mallinckrodt
2.9.1 Mallinckrodt Details
2.9.2 Mallinckrodt Major Business
2.9.3 Mallinckrodt Cannabis Use Disorder Treatment Product and Solutions
2.9.4 Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mallinckrodt Recent Developments and Future Plans
2.10 Noramco
2.10.1 Noramco Details
2.10.2 Noramco Major Business
2.10.3 Noramco Cannabis Use Disorder Treatment Product and Solutions
2.10.4 Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Noramco Recent Developments and Future Plans
2.11 Orexo AB
2.11.1 Orexo AB Details
2.11.2 Orexo AB Major Business
2.11.3 Orexo AB Cannabis Use Disorder Treatment Product and Solutions
2.11.4 Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Orexo AB Recent Developments and Future Plans
2.12 Purdue Pharma
2.12.1 Purdue Pharma Details
2.12.2 Purdue Pharma Major Business
2.12.3 Purdue Pharma Cannabis Use Disorder Treatment Product and Solutions
2.12.4 Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Purdue Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cannabis Use Disorder Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cannabis Use Disorder Treatment by Company Revenue
3.2.2 Top 3 Cannabis Use Disorder Treatment Players Market Share in 2022
3.2.3 Top 6 Cannabis Use Disorder Treatment Players Market Share in 2022
3.3 Cannabis Use Disorder Treatment Market: Overall Company Footprint Analysis
3.3.1 Cannabis Use Disorder Treatment Market: Region Footprint
3.3.2 Cannabis Use Disorder Treatment Market: Company Product Type Footprint
3.3.3 Cannabis Use Disorder Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cannabis Use Disorder Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cannabis Use Disorder Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Cannabis Use Disorder Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
6.2 North America Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
6.3 North America Cannabis Use Disorder Treatment Market Size by Country
6.3.1 North America Cannabis Use Disorder Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
7.2 Europe Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
7.3 Europe Cannabis Use Disorder Treatment Market Size by Country
7.3.1 Europe Cannabis Use Disorder Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7.3.3 France Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region
8.3.1 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Region (2018-2029)
8.3.2 China Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.5 India Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
9.2 South America Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
9.3 South America Cannabis Use Disorder Treatment Market Size by Country
9.3.1 South America Cannabis Use Disorder Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country
10.3.1 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Cannabis Use Disorder Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cannabis Use Disorder Treatment Market Drivers
11.2 Cannabis Use Disorder Treatment Market Restraints
11.3 Cannabis Use Disorder Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Cannabis Use Disorder Treatment Industry Chain
12.2 Cannabis Use Disorder Treatment Upstream Analysis
12.3 Cannabis Use Disorder Treatment Midstream Analysis
12.4 Cannabis Use Disorder Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cannabis Use Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cannabis Use Disorder Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cannabis Use Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cannabis Use Disorder Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Cannabis Use Disorder Treatment Product and Solutions
Table 8. AbbVie Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Alkermes Company Information, Head Office, and Major Competitors
Table 11. Alkermes Major Business
Table 12. Alkermes Cannabis Use Disorder Treatment Product and Solutions
Table 13. Alkermes Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Alkermes Recent Developments and Future Plans
Table 15. BioCorRx Company Information, Head Office, and Major Competitors
Table 16. BioCorRx Major Business
Table 17. BioCorRx Cannabis Use Disorder Treatment Product and Solutions
Table 18. BioCorRx Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. BioCorRx Recent Developments and Future Plans
Table 20. Cipla Limited Company Information, Head Office, and Major Competitors
Table 21. Cipla Limited Major Business
Table 22. Cipla Limited Cannabis Use Disorder Treatment Product and Solutions
Table 23. Cipla Limited Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Cipla Limited Recent Developments and Future Plans
Table 25. Dr. Reddy’s Laboratories Company Information, Head Office, and Major Competitors
Table 26. Dr. Reddy’s Laboratories Major Business
Table 27. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Solutions
Table 28. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Dr. Reddy’s Laboratories Recent Developments and Future Plans
Table 30. Glenmark Pharmaceuticals Limited Company Information, Head Office, and Major Competitors
Table 31. Glenmark Pharmaceuticals Limited Major Business
Table 32. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
Table 33. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Glenmark Pharmaceuticals Limited Recent Developments and Future Plans
Table 35. Intas Pharmaceuticals Limited Company Information, Head Office, and Major Competitors
Table 36. Intas Pharmaceuticals Limited Major Business
Table 37. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
Table 38. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Intas Pharmaceuticals Limited Recent Developments and Future Plans
Table 40. Indivior Company Information, Head Office, and Major Competitors
Table 41. Indivior Major Business
Table 42. Indivior Cannabis Use Disorder Treatment Product and Solutions
Table 43. Indivior Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Indivior Recent Developments and Future Plans
Table 45. Mallinckrodt Company Information, Head Office, and Major Competitors
Table 46. Mallinckrodt Major Business
Table 47. Mallinckrodt Cannabis Use Disorder Treatment Product and Solutions
Table 48. Mallinckrodt Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Mallinckrodt Recent Developments and Future Plans
Table 50. Noramco Company Information, Head Office, and Major Competitors
Table 51. Noramco Major Business
Table 52. Noramco Cannabis Use Disorder Treatment Product and Solutions
Table 53. Noramco Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Noramco Recent Developments and Future Plans
Table 55. Orexo AB Company Information, Head Office, and Major Competitors
Table 56. Orexo AB Major Business
Table 57. Orexo AB Cannabis Use Disorder Treatment Product and Solutions
Table 58. Orexo AB Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Orexo AB Recent Developments and Future Plans
Table 60. Purdue Pharma Company Information, Head Office, and Major Competitors
Table 61. Purdue Pharma Major Business
Table 62. Purdue Pharma Cannabis Use Disorder Treatment Product and Solutions
Table 63. Purdue Pharma Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Purdue Pharma Recent Developments and Future Plans
Table 65. Global Cannabis Use Disorder Treatment Revenue (USD Million) by Players (2018-2023)
Table 66. Global Cannabis Use Disorder Treatment Revenue Share by Players (2018-2023)
Table 67. Breakdown of Cannabis Use Disorder Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Cannabis Use Disorder Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Cannabis Use Disorder Treatment Players
Table 70. Cannabis Use Disorder Treatment Market: Company Product Type Footprint
Table 71. Cannabis Use Disorder Treatment Market: Company Product Application Footprint
Table 72. Cannabis Use Disorder Treatment New Market Entrants and Barriers to Market Entry
Table 73. Cannabis Use Disorder Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Cannabis Use Disorder Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Cannabis Use Disorder Treatment Consumption Value Share by Type (2018-2023)
Table 76. Global Cannabis Use Disorder Treatment Consumption Value Forecast by Type (2024-2029)
Table 77. Global Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023)
Table 78. Global Cannabis Use Disorder Treatment Consumption Value Forecast by Application (2024-2029)
Table 79. North America Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Cannabis Use Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Cannabis Use Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Cannabis Use Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Cannabis Use Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Cannabis Use Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Cannabis Use Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Cannabis Use Disorder Treatment Raw Material
Table 110. Key Suppliers of Cannabis Use Disorder Treatment Raw Materials
Table 1. Global Cannabis Use Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cannabis Use Disorder Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cannabis Use Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cannabis Use Disorder Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Cannabis Use Disorder Treatment Product and Solutions
Table 8. AbbVie Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Alkermes Company Information, Head Office, and Major Competitors
Table 11. Alkermes Major Business
Table 12. Alkermes Cannabis Use Disorder Treatment Product and Solutions
Table 13. Alkermes Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Alkermes Recent Developments and Future Plans
Table 15. BioCorRx Company Information, Head Office, and Major Competitors
Table 16. BioCorRx Major Business
Table 17. BioCorRx Cannabis Use Disorder Treatment Product and Solutions
Table 18. BioCorRx Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. BioCorRx Recent Developments and Future Plans
Table 20. Cipla Limited Company Information, Head Office, and Major Competitors
Table 21. Cipla Limited Major Business
Table 22. Cipla Limited Cannabis Use Disorder Treatment Product and Solutions
Table 23. Cipla Limited Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Cipla Limited Recent Developments and Future Plans
Table 25. Dr. Reddy’s Laboratories Company Information, Head Office, and Major Competitors
Table 26. Dr. Reddy’s Laboratories Major Business
Table 27. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Solutions
Table 28. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Dr. Reddy’s Laboratories Recent Developments and Future Plans
Table 30. Glenmark Pharmaceuticals Limited Company Information, Head Office, and Major Competitors
Table 31. Glenmark Pharmaceuticals Limited Major Business
Table 32. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
Table 33. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Glenmark Pharmaceuticals Limited Recent Developments and Future Plans
Table 35. Intas Pharmaceuticals Limited Company Information, Head Office, and Major Competitors
Table 36. Intas Pharmaceuticals Limited Major Business
Table 37. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
Table 38. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Intas Pharmaceuticals Limited Recent Developments and Future Plans
Table 40. Indivior Company Information, Head Office, and Major Competitors
Table 41. Indivior Major Business
Table 42. Indivior Cannabis Use Disorder Treatment Product and Solutions
Table 43. Indivior Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Indivior Recent Developments and Future Plans
Table 45. Mallinckrodt Company Information, Head Office, and Major Competitors
Table 46. Mallinckrodt Major Business
Table 47. Mallinckrodt Cannabis Use Disorder Treatment Product and Solutions
Table 48. Mallinckrodt Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Mallinckrodt Recent Developments and Future Plans
Table 50. Noramco Company Information, Head Office, and Major Competitors
Table 51. Noramco Major Business
Table 52. Noramco Cannabis Use Disorder Treatment Product and Solutions
Table 53. Noramco Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Noramco Recent Developments and Future Plans
Table 55. Orexo AB Company Information, Head Office, and Major Competitors
Table 56. Orexo AB Major Business
Table 57. Orexo AB Cannabis Use Disorder Treatment Product and Solutions
Table 58. Orexo AB Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Orexo AB Recent Developments and Future Plans
Table 60. Purdue Pharma Company Information, Head Office, and Major Competitors
Table 61. Purdue Pharma Major Business
Table 62. Purdue Pharma Cannabis Use Disorder Treatment Product and Solutions
Table 63. Purdue Pharma Cannabis Use Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Purdue Pharma Recent Developments and Future Plans
Table 65. Global Cannabis Use Disorder Treatment Revenue (USD Million) by Players (2018-2023)
Table 66. Global Cannabis Use Disorder Treatment Revenue Share by Players (2018-2023)
Table 67. Breakdown of Cannabis Use Disorder Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Cannabis Use Disorder Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Cannabis Use Disorder Treatment Players
Table 70. Cannabis Use Disorder Treatment Market: Company Product Type Footprint
Table 71. Cannabis Use Disorder Treatment Market: Company Product Application Footprint
Table 72. Cannabis Use Disorder Treatment New Market Entrants and Barriers to Market Entry
Table 73. Cannabis Use Disorder Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Cannabis Use Disorder Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Cannabis Use Disorder Treatment Consumption Value Share by Type (2018-2023)
Table 76. Global Cannabis Use Disorder Treatment Consumption Value Forecast by Type (2024-2029)
Table 77. Global Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023)
Table 78. Global Cannabis Use Disorder Treatment Consumption Value Forecast by Application (2024-2029)
Table 79. North America Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Cannabis Use Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Cannabis Use Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Cannabis Use Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Cannabis Use Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Cannabis Use Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Cannabis Use Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Cannabis Use Disorder Treatment Raw Material
Table 110. Key Suppliers of Cannabis Use Disorder Treatment Raw Materials
LIST OF FIGURES
Figure 1. Cannabis Use Disorder Treatment Picture
Figure 2. Global Cannabis Use Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cannabis Use Disorder Treatment Consumption Value Market Share by Type in 2022
Figure 4. Tobacco/Nicotine and Vaping
Figure 5. Alcohol
Figure 6. Marijuana
Figure 7. Synthetic Cannabinoids
Figure 8. Others
Figure 9. Global Cannabis Use Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Cannabis Use Disorder Treatment Consumption Value Market Share by Application in 2022
Figure 11. Hospitals and Clinics Picture
Figure 12. Rehabilitation Centers Picture
Figure 13. Others Picture
Figure 14. Global Cannabis Use Disorder Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Cannabis Use Disorder Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Cannabis Use Disorder Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Cannabis Use Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Cannabis Use Disorder Treatment Consumption Value Market Share by Region in 2022
Figure 19. North America Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Cannabis Use Disorder Treatment Revenue Share by Players in 2022
Figure 25. Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Cannabis Use Disorder Treatment Market Share in 2022
Figure 27. Global Top 6 Players Cannabis Use Disorder Treatment Market Share in 2022
Figure 28. Global Cannabis Use Disorder Treatment Consumption Value Share by Type (2018-2023)
Figure 29. Global Cannabis Use Disorder Treatment Market Share Forecast by Type (2024-2029)
Figure 30. Global Cannabis Use Disorder Treatment Consumption Value Share by Application (2018-2023)
Figure 31. Global Cannabis Use Disorder Treatment Market Share Forecast by Application (2024-2029)
Figure 32. North America Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Cannabis Use Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Cannabis Use Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. France Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 49. China Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. India Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Cannabis Use Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Cannabis Use Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 66. Cannabis Use Disorder Treatment Market Drivers
Figure 67. Cannabis Use Disorder Treatment Market Restraints
Figure 68. Cannabis Use Disorder Treatment Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Cannabis Use Disorder Treatment in 2022
Figure 71. Manufacturing Process Analysis of Cannabis Use Disorder Treatment
Figure 72. Cannabis Use Disorder Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Cannabis Use Disorder Treatment Picture
Figure 2. Global Cannabis Use Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cannabis Use Disorder Treatment Consumption Value Market Share by Type in 2022
Figure 4. Tobacco/Nicotine and Vaping
Figure 5. Alcohol
Figure 6. Marijuana
Figure 7. Synthetic Cannabinoids
Figure 8. Others
Figure 9. Global Cannabis Use Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Cannabis Use Disorder Treatment Consumption Value Market Share by Application in 2022
Figure 11. Hospitals and Clinics Picture
Figure 12. Rehabilitation Centers Picture
Figure 13. Others Picture
Figure 14. Global Cannabis Use Disorder Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Cannabis Use Disorder Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Cannabis Use Disorder Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Cannabis Use Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Cannabis Use Disorder Treatment Consumption Value Market Share by Region in 2022
Figure 19. North America Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Cannabis Use Disorder Treatment Revenue Share by Players in 2022
Figure 25. Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Cannabis Use Disorder Treatment Market Share in 2022
Figure 27. Global Top 6 Players Cannabis Use Disorder Treatment Market Share in 2022
Figure 28. Global Cannabis Use Disorder Treatment Consumption Value Share by Type (2018-2023)
Figure 29. Global Cannabis Use Disorder Treatment Market Share Forecast by Type (2024-2029)
Figure 30. Global Cannabis Use Disorder Treatment Consumption Value Share by Application (2018-2023)
Figure 31. Global Cannabis Use Disorder Treatment Market Share Forecast by Application (2024-2029)
Figure 32. North America Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Cannabis Use Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Cannabis Use Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. France Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Cannabis Use Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 49. China Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. India Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Cannabis Use Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Cannabis Use Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Cannabis Use Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 66. Cannabis Use Disorder Treatment Market Drivers
Figure 67. Cannabis Use Disorder Treatment Market Restraints
Figure 68. Cannabis Use Disorder Treatment Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Cannabis Use Disorder Treatment in 2022
Figure 71. Manufacturing Process Analysis of Cannabis Use Disorder Treatment
Figure 72. Cannabis Use Disorder Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
